These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 26835543)

  • 41. Identification of Genetic and Environmental Factors Predicting Metabolically Healthy Obesity in Children: Data From the BCAMS Study.
    Li L; Yin J; Cheng H; Wang Y; Gao S; Li M; Grant SF; Li C; Mi J; Li M
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1816-25. PubMed ID: 26913634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity.
    Denimal D; Monier S; Bouillet B; Vergès B; Duvillard L
    Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.
    Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Robin I; Taskinen MR
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4281-90. PubMed ID: 25077901
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
    J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
    Ooi EM; Watts GF; Chan DC; Nielsen LB; Plomgaard P; Dahlbäck B; Barrett PH
    Atherosclerosis; 2010 May; 210(1):326-30. PubMed ID: 20031132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes.
    Bach-Ngohou K; Ouguerram K; Nazih H; Maugère P; Ripolles-Piquer B; Zaïr Y; Frénais R; Krempf M; Bard JM
    Int J Obes Relat Metab Disord; 2002 Nov; 26(11):1451-8. PubMed ID: 12439646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HDL-apoA-I kinetics in response to 16 wk of exercise training in men with nonalcoholic fatty liver disease.
    Whyte MB; Shojaee-Moradie F; Sharaf SE; Cuthbertson DJ; Kemp GJ; Barrett M; Jackson NC; Herring RA; Wright J; Thomas EL; Bell J; Umpleby AM
    Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E839-E847. PubMed ID: 32286882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity.
    Vergès B; Adiels M; Boren J; Barrett PH; Watts GF; Chan D; Duvillard L; Söderlund S; Matikainen N; Kahri J; Lundbom N; Lundbom J; Hakkarainen A; Aho S; Simoneau-Robin I; Taskinen MR
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1398-406. PubMed ID: 26835543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.
    Chan DC; Ng TW; Watts GF
    Ann Med; 2012 Jun; 44(4):313-24. PubMed ID: 21501035
    [TBL] [Abstract][Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.